Three-Year Follow-Up of Neoadjuvant Tislelizumab with Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Revealing Cancer-Associated Fibroblast Heterogeneity Corresponding to PD-1 Blockade Efficacy.
局部晚期胃癌和胃食管交界处腺癌新辅助替雷利珠单抗联合化疗三年随访:揭示与 PD-1 阻断疗效相对应的癌症相关成纤维细胞异质性。
期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202508433
Lin Yao, Sun Xiong, Li Chengguo, Yang Ming, Wu Ke, Liu Ke, Li Anshu, Shuai Xiaoming, Cai Kailin, Wang Zheng, Wang Guobin, Zhang Peng, Shen Jianfeng, Tao Kaixiong, Yin Yuping